Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01547845 · ClinicalTrials.gov registry record
Cancer Symptom Data From Multiple Treatment Centers
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,517
- Enrollment target
NCT01547845: Completed study, sponsored by National Cancer Institute (NCI).
NCT01547845 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,517 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01547845 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,517 participants
- Enrollment target
Study Summary
Background: \- Cancer and cancer treatments can cause symptoms and side effects. Pain, fatigue, and emotional distress are three common symptoms. Accurate reporting of these symptoms can improve treatment methods and outcomes. Even though symptom reporting is important to treatment, there is no method to collect and compare patient data from multiple cancer care centers. Researchers want to develop a method for collecting cancer patient symptom information from multiple centers. This method may help improve cancer treatment at hospitals and other care centers. Objectives: \- To collect patient-reported symptom information from multiple cancer care centers. Eligibility: * Individuals at least 21 years of age who were treated for breast or colon cancer in the past year. * Participants will come from one of the participating cancer care centers. Design: * Participants will answer a short questionnaire about their symptoms during cancer treatment. Questions will ask about symptom severity and experiences. Other questions will ask how well the doctors and nurses managed the symptoms. * Participant responses will be compared with other medical and personal information. This information may include cancer type, age at diagnosis, and type of treatment. * Treatment will not be provided as part of this study.
Primary Outcome
Complete reporting of symptoms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,517 participants |
| Start Date | 2012-02-10 |
| Est. Completion | 2019-05-23 |
What the finished NCT01547845 record still lists
NCT01547845 is an observational study that tracks outcomes without assigning an intervention. Its 2,517 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01547845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01547845 about?
NCT01547845 is a clinical study titled "Cancer Symptom Data From Multiple Treatment Centers". Background: \- Cancer and cancer treatments can cause symptoms and side effects. Pain, fatigue, and emotional distress are three common symptoms. Accurate reporting of these symptoms can improve treatment methods and outcomes. Even though symptom reporting is important to treatment, there is no met...
What is the current status of trial NCT01547845?
This trial is currently completed. The enrollment target is 2,517 participants. The study started on 2012-02-10. Estimated completion is 2019-05-23.
Who is sponsoring clinical trial NCT01547845?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04142177 · 2,529 participants · NA
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
- NCT00018057 · 2,530 participants · Phase 2
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI